Skip to content
Lower risk Medical device recall · FDA · Published February 5, 2026

Stago STA Liatest D-Di: Positive bias in D-dimer measurements

Stago recalls STA Liatest D-Di kits with REF 00515 due to potential positive bias in D-dimer measurements, which could lead to inaccurate blood test results.

🇺🇸 FDA recall #Z-1585-2026Medical deviceStago ›
Take action

Contact the company

Recalling firmDiagnostica Stago, Inc.5 Century Dr · Parsippany, NJ 07054-4607
✎ GovInfoNow plain-language explainer

Stago is recalling STA Liatest D-Di blood test kits with model REF 00515 because they may give falsely high D-dimer results. This could lead to incorrect diagnoses of blood clotting conditions. Read more at govinfonow.com/recall/50048-stago-sta-liatest-d-di-positive-bias-in-d-dimer.

Source Summary by GovInfoNow · govinfonow.com/recall/50048-stago-sta-liatest-d-di-positive-bias-in-d-dimer · Updated August 10, 2026 · FDA enforcement record: FDA #Z-1585-2026

Cite this page

“Stago STA Liatest D-Di: Positive bias in D-dimer measurements.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/50048-stago-sta-liatest-d-di-positive-bias-in-d-dimer. Based on FDA recall #Z-1585-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1585-2026%22&limit=1).

Diagnostica Stago, Inc. recalled STA Liatest D-Di in vitro diagnostic kits due to a positive bias in D-Dimer measurements, the FDA said on Feb. 5, 2026. The agency announced the Class II recall after investigations confirmed the issue throughout the entire analytical range.

How to tell if you have it

  • Brand: STA Liatest D-Di
  • Model/Catalog Number: REF 00515
  • UPC: 03607450005158
  • Lot numbers: 273015, 273127, 273275, 273567, 273681, 273808, 273995, 274108, 273128, 273606, 273805, 274219

The hazard

Investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range. The recall was initiated after receiving customer complaints.

Context

GovInfoNow's records show Diagnostica Stago, Inc. has 12 other recalls on record since 2017-10-25. Other recent recalls of similar products include Diagnostica Stago STA Staclot Protein S Recall (2026-07-29), Stago STA Liatest Free Protein S (2026-02-04), and Diagnostica Stago Asserachrom HPIA Kit Recall (2025-12-15). Other recent recalls of similar products include GET TESTED D-Dimer Test Recall (2025-11-03) and Immunotech Estrone RIA Kit Recall (2025-12-15).

How to tell if you have this one

Check for model number REF 00515 on the kit. The kit is sold with specific lot numbers listed in the recall notice. It is used with STA-R, STA Compact, or STA Satellite analyzers in labs.

  • Brand
    Stago
  • Product
    Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: in
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Model

    Look for model number REF 00515 on the kit packaging or label.

  2. Contact Manufacturer

    Reach out to Diagnostica Stago, Inc. for further assistance with the recall.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the countries of Canada, Singapore, Guam, Japan, South Korea, and Russia.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 48 days after the firm started it.

1. Firm started the recall: Feb 5, 202612. FDA classified it Class II: Mar 19, 202623. Published in FDA’s Enforcement Report: Mar 25, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1585-2026 (February 5, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1585-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA